'Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise Concerns Moderna is currently developing a promising, yet...
'Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise Concerns
Moderna is currently developing a promising, yet still unproven, vaccine against the coronavirus. But Moderna executives have already sold tens of millions of dollars worth of stock in the company.
Read more on NPR
Moderna is currently developing a promising, yet still unproven, vaccine against the coronavirus. But Moderna executives have already sold tens of millions of dollars worth of stock in the company.
Read more on NPR
